Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 22308973)

1.

Genetic variants associated with predisposition to prostate cancer and potential clinical implications.

Goh CL, Schumacher FR, Easton D, Muir K, Henderson B, Kote-Jarai Z, Eeles RA.

J Intern Med. 2012 Apr;271(4):353-65. doi: 10.1111/j.1365-2796.2012.02511.x. Erratum in: J Intern Med. 2013 May;273(5):527.

PMID:
22308973
2.

The genetic epidemiology of prostate cancer and its clinical implications.

Eeles R, Goh C, Castro E, Bancroft E, Guy M, Al Olama AA, Easton D, Kote-Jarai Z.

Nat Rev Urol. 2014 Jan;11(1):18-31. doi: 10.1038/nrurol.2013.266. Epub 2013 Dec 3. Review.

PMID:
24296704
3.

Genetics of prostate cancer risk.

Pomerantz MM, Freedman ML.

Mt Sinai J Med. 2010 Nov-Dec;77(6):643-54. doi: 10.1002/msj.20222. Review.

PMID:
21105126
4.

A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.

Ishak MB, Giri VN.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1599-610. doi: 10.1158/1055-9965.EPI-11-0312. Epub 2011 Jun 29. Review.

5.

Meta-analysis of genome-wide and replication association studies on prostate cancer.

Liu H, Wang B, Han C.

Prostate. 2011 Feb 1;71(2):209-24. doi: 10.1002/pros.21235. Review.

PMID:
20690139
6.

The role of genetic markers in the management of prostate cancer.

Choudhury AD, Eeles R, Freedland SJ, Isaacs WB, Pomerantz MM, Schalken JA, Tammela TL, Visakorpi T.

Eur Urol. 2012 Oct;62(4):577-87. doi: 10.1016/j.eururo.2012.05.054. Epub 2012 Jun 5. Review.

PMID:
22695242
7.

Inherited susceptibility for aggressive prostate cancer.

Isaacs WB.

Asian J Androl. 2012 May;14(3):415-8. doi: 10.1038/aja.2011.146. Epub 2012 Apr 30. Review.

8.

Inherited predisposition to prostate cancer.

Verhage BA, Kiemeney LA.

Eur J Epidemiol. 2003;18(11):1027-36. Review.

PMID:
14620936
9.

Prostate cancer genomics, biology, and risk assessment through genome-wide association studies.

Nakagawa H, Akamatsu S, Takata R, Takahashi A, Kubo M, Nakamura Y.

Cancer Sci. 2012 Apr;103(4):607-13. doi: 10.1111/j.1349-7006.2011.02193.x. Epub 2012 Jan 29. Review.

PMID:
22181854
10.

Perspective: prostate cancer susceptibility genes.

Simard J, Dumont M, Soucy P, Labrie F.

Endocrinology. 2002 Jun;143(6):2029-40. Review.

PMID:
12021166
11.

Genome-wide association studies in common cancers--what have we learnt?

Varghese JS, Easton DF.

Curr Opin Genet Dev. 2010 Jun;20(3):201-9. doi: 10.1016/j.gde.2010.03.012. Epub 2010 Apr 24. Review.

PMID:
20418093
12.

[Clinical and basic aspects of familial prostate cancer].

Suzuki K, Matsui H, Ohtake N.

Gan To Kagaku Ryoho. 2013 Feb;40(2):159-63. Review. Japanese.

PMID:
23411953
13.

Prostate cancer: germline prediction for a commonly variable malignancy.

Bambury RM, Gallagher DJ.

BJU Int. 2012 Dec;110(11 Pt C):E809-18. doi: 10.1111/j.1464-410X.2012.11450.x. Epub 2012 Sep 14. Review.

PMID:
22974436
14.

Molecular epidemiology of androgen-metabolic loci in prostate cancer: predisposition and progression.

Makridakis NM, Reichardt JK.

J Urol. 2004 Feb;171(2 Pt 2):S25-8; discussion S28-9. Review.

PMID:
14713749
15.

AIDIT and IMPACT: building research collaborations in targeted prostate cancer screening.

Doherty R, Lubinski J, Manguoglu E, Luleci G, Christie M, Craven P, Bancroft E, Mitra A, Morgan S, Eeles R; IMPACT Steering Committee.

J BUON. 2006 Oct-Dec;11(4):415-8. Review.

PMID:
17309171
16.

Prostate cancer susceptibility genes: lessons learned and challenges posed.

Simard J, Dumont M, Labuda D, Sinnett D, Meloche C, El-Alfy M, Berger L, Lees E, Labrie F, Tavtigian SV.

Endocr Relat Cancer. 2003 Jun;10(2):225-59. Review.

17.

Identification of new genetic risk factors for prostate cancer.

Guy M, Kote-Jarai Z, Giles GG, Al Olama AA, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL; UK Genetic Prostate Cancer Study Collaborators; British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jameson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF, Eeles RA.

Asian J Androl. 2009 Jan;11(1):49-55. doi: 10.1038/aja.2008.18. Epub 2008 Dec 1. Review.

18.

The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.

Van den Broeck T, Joniau S, Clinckemalie L, Helsen C, Prekovic S, Spans L, Tosco L, Van Poppel H, Claessens F.

Biomed Res Int. 2014;2014:627510. doi: 10.1155/2014/627510. Epub 2014 Feb 19. Review.

19.

Genetic analysis of the principal genes related to prostate cancer: a review.

Alvarez-Cubero MJ, Saiz M, Martinez-Gonzalez LJ, Alvarez JC, Lorente JA, Cozar JM.

Urol Oncol. 2013 Nov;31(8):1419-29. doi: 10.1016/j.urolonc.2012.07.011. Epub 2012 Nov 7. Review.

PMID:
23141781
20.

Implications of genome-wide association studies in cancer therapeutics.

Patel JN, McLeod HL, Innocenti F.

Br J Clin Pharmacol. 2013 Sep;76(3):370-80. doi: 10.1111/bcp.12166. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk